General Information of the Compound
Compound ID |
CP0454836
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-(1H-benzimidazol-2-ylmethyl)-5-benzyl-1,3,4-oxadiazole
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H14N4O
|
||||||||||||||||||
Molecular Weight |
290.326
|
||||||||||||||||||
Canonical SMILES |
C(c1nc2ccccc2[nH]1)c1nnc(Cc2ccccc2)o1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H14N4O/c1-2-6-12(7-3-1)10-16-20-21-17(22-16)11-15-18-13-8-4-5-9-14(13)19-15/h1-9H,10-11H2,(H,18,19)
Show/Hide
|
||||||||||||||||||
InChIKey |
VMYNFFQXYNOIEA-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01233, Receptor tyrosine-protein kinase erbB-2
Cell Viability or Cytotoxicity Assay